<DOC>
	<DOCNO>NCT00454402</DOCNO>
	<brief_summary>The aim study assess effect Alfuzosin compare placebo , 7 day , outcome patient uretheric stone submit Extracorporeal Shock Wave Lithotripsy ( ESWL ) , namely percentage patient without imagiologic evidence stone 72h 96 hour . This study also specifically focus evaluation time stone clearance pain reduction ( Numeric Rating Scale ) .</brief_summary>
	<brief_title>ALF-STONE : Alfuzosin Uretheric Stones</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Inclusion criterion : Patients imagiologic evidence uretheric stone Exclusion criterion : Women pregnant breast feeding Patients renal impairment ( creatinine &gt; 2mg/dl ) The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>